NPI registry status
Active
2026 NPPES data Optometrist NPI 1487017075
Verify on CMS → Paul Nefedov
Optometrist in Longview, Washington.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 60,484 in Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
644
Medicare Part D claims · 201 beneficiaries · Optometrist avg: 257
Generic prescribing
54%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
97.8/100
▲ 15 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Paul Nefedov reported a CMS MIPS final score of 97.8/100 - above the 83.1 national average - and filed 644 Medicare Part D claims in 2023.
- 97.8/100
- MIPS score · +15 vs avg
- 644
- Part D claims, 2023
- 54%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Paul Nefedov's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
98 Top 15% higher than 85% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Paul Nefedov sits
This provider among optometrist peers
Across the 6,527 optometrist providers who report both Medicare Part D prescribing and a MIPS quality score, Paul Nefedov writes more Part D claims than 71% of them and scores higher on MIPS quality than 85% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one optometrist peer from a representative sample of 60; the gold marker is Paul Nefedov. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Paul Nefedov?
High performer (top quartile)Primary specialty
Optometrist
Medicare Part D claims
644 151% vs specialty avg
MIPS final score
97.8/100 14.7 pts vs avg
Specialty distribution in Washington
How Optometrist compares to other specialties among Washington providers
Medicare quality performance, MIPS
Paul Nefedov's 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 97.8/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) - 97.8/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Paul Nefedov appears in the CMS NPPES registry as an Optometrist provider at 600 TRIANGLE CTR STE 400, Longview, WA, 98632, with a listed phone of (360) 423-0220. NPI 1487017075 was issued on 03/31/2016.
Medicare Part D records for calendar year 2023 show 644 prescription claims written by this provider, covering 201 Medicare beneficiaries and totaling roughly $71K in drug spend, split 46% brand-name and 54% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 97.8/100 for the 2023 performance year (Quality 81), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,484 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487017075 |
|---|---|
| Specialty | Optometrist |
| Gender | Male |
| NPI Issued | 03/31/2016 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
97.83
Final Score
Avg: 83.1
80.9759
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Paul Nefedov bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Pacific University
Forest Grove, OR
University Professional Services
Astoria, OR
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Washington WMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 - they are NOT specific to Paul Nefedov. To verify Paul Nefedov's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Paul Nefedov - brand share 46.0%
Optometrist average
46% brand-name claims vs 54% generic, on 644 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
644
Total Claims
$71K
Total Drug Cost
201
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 801
- Total Day Supply
- 19,556
- Brand vs Generic
- 46% brand / 54% generic
- Brand Drug Cost
- $61K
- Generic Drug Cost
- $10K
- Antibiotic Claims
- 51
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 1.39
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 21, 65-74: 79, 75-84: 73, 85+: 28
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Paul Nefedov prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
218 claims
- Neomycin-Polymyxin… 74
Neomycin-Polymyxin-Dexameth
74 claims
- Dorzolamide-Timolol 59
Dorzolamide-Timolol
59 claims
- Brimonidine Tartrate 44
Brimonidine Tartrate
44 claims
- Doxycycline Monohy… 37
Doxycycline Monohydrate
37 claims
- Tobramycin-Dexamet… 35
Tobramycin-Dexamethasone
35 claims
- Restasis 23
Restasis
23 claims
- Restasis Multidose 21
Restasis Multidose
21 claims
| Drug | Claims |
|---|---|
| Latanoprost | 218 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 74 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 59 |
| Brimonidine Tartrate | 44 |
| Doxycycline Monohydrate | 37 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 35 |
| Restasis Cyclosporine | 23 |
| Restasis Multidose Cyclosporine | 21 |
| Prednisolone Acetate | 20 |
| Cyclosporine | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How Paul Nefedov fits within the Optometrist landscape nationally.
60,484
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider
Paul Nefedov's 644 claims are above the specialty average of 257.
Nearby Optometrist Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as Nefedov.
Dr. Jenni Aaseby
O.D.
Shelton, WA
Dr. Meagan-Rhose Abanto
OD
Everett, WA
Dr. Jabeen Abdulla
O.D.
Tacoma, WA
Dr. James Abel
OD
Renton, WA
Dr. Christina Abercrombie
OD
Kent, WA
Compare Optometrist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Washington medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Optometrist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Washington
Frequently Asked Questions
What is Paul Nefedov's specialty? ▼
Paul Nefedov specializes in Optometrist and practices in Longview, Washington.
How much does Paul Nefedov prescribe under Medicare Part D? ▼
In 2023, Paul Nefedov wrote 644 Medicare Part D claims totaling $71K in drug costs for 201 beneficiaries.
What is Paul Nefedov's Medicare quality score? ▼
Paul Nefedov has a CMS MIPS Final Score of 97.8/100 (Quality: 81). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Paul Nefedov located? ▼
Paul Nefedov is located at 600 TRIANGLE CTR STE 400, Longview, WA, 98632. Phone: (360) 423-0220.
What is Paul Nefedov's NPI number? ▼
Paul Nefedov's National Provider Identifier (NPI) is 1487017075, issued on 03/31/2016.
Does Paul Nefedov prescribe more brand-name or generic drugs? ▼
Paul Nefedov's prescribing is 46% brand-name and 54% generic drugs by claim count, with $61K in brand drug costs.
How many Optometrist providers are there in the US? ▼
There are 60,484 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does Paul Nefedov prescribe most often? ▼
Based on 2023 Medicare Part D data, Paul Nefedov's most frequently prescribed drugs include Latanoprost, Neomycin-Polymyxin-Dexameth, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Paul Nefedov accept Medicare? ▼
Paul Nefedov appears in CMS Medicare data with 644 Part D claims and 201 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Paul Nefedov's credentials? ▼
Paul Nefedov's NPI is 1487017075. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.